
Frontiers in Endocrinology, Journal Year: 2024, Volume and Issue: 15
Published: Oct. 8, 2024
Background Preeclampsia (PE) is a condition in pregnancy characterized by hypertension and proteinuria, thus leading to severe complications for both mother fetus, including fetal growth restriction (FGR). However, there are still unclear aspects regarding the pathogenesis, prevention, treatments. This study aimed elucidate characteristics of lipid metabolism maternal umbilical cord plasma complicated with PE using liquid chromatography-mass spectrometry (LC-MS). Method The included singleton pregnant women at Osaka Metropolitan University Hospital from March 2023 February 2024. was diagnosed based on new-onset after 20 weeks gestation other symptoms such as proteinuria organ dysfunction. FGR defined ultrasound measurements below -1.5 standard deviation (SD). Plasma samples were collected blood within 24 hours before delivery. Lipid metabolites comprehensively analyzed LC-MS, lipokine 12,13-diHOME, identified elevated comprehensive analysis, quantified. Immunohistochemistry conducted placental assess soluble epoxide hydrolase (sEH) expression. Results involved 31 participants, control group 11 group. A analysis significant increase 12,13-diHOME levels compared Quantification showed plasma, venous arterial ( p = 0.007, 0.008, 0.005). significantly higher concentrations arterial/venous ratio without 0.03). Negative correlations observed between birth weight did not show differences sEH expression groups. Conclusion demonstrated that patients, particularly FGR. Elevated may reflect progression ischemia due pathogenesis. metabolite could serve marker severity preeclampsia, providing new insights into perinatal lipidomics potential role PE.
Language: Английский